Tandem Diabetes Care (TNDM)

Common Shares
Sell: $21.88|Buy: $22.51|Change: 0.27 (1.24%)

Company profile

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Address

11075 Roselle Street
San Diego
CA
USA
92121


Telephone

+1 858 3666900


Sector 

Healthcare


Previous key dates

NameKey Date
Piper Sandler 37 Annual Healthcare Conference2025-12-02T10:30:00
Stifel 2025 Healthcare Conference2025-11-11T10:30:00
Tandem Diabetes Care Inc Third Quarter Earnings Conference Call for 20252025-11-06T16:30:00
Tandem Diabetes Care Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00
Healthcare Leaders and Disruptors 2nd Annual Healthcare2025-09-24T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T09:15:00
Tandem Diabetes Care Inc Second Quarter Earnings Conference Call for 20252025-08-06T16:30:00
Tandem Diabetes Care Inc Second Quarter Earnings Result for 20252025-08-06T00:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-10T08:40:00
Jefferies Global Healthcare Conference2025-06-04T15:45:00
Tandem Diabetes Care Inc Annual General Meeting for 20252025-05-21T15:00:00
2025 RBC Capital Markets Global Healthcare Conference2025-05-20T10:00:00
Tandem Diabetes Care Inc First Quarter Earnings Conference Call for 20252025-04-30T16:30:00
Tandem Diabetes Care Inc First Quarter Earnings Results for 20252025-04-30T00:00:00
Oppenheimer 35th Annual Healthcare MedTech & Services Conference2025-03-20T12:40:00
Leerink Partners 2025 Global Healthcare Conference2025-03-12T09:20:00
Barclays 27th Annual Global Healthcare Conference2025-03-11T13:30:00
TD Cowen 45th Annual Health Care Conference2025-03-04T13:50:00
Tandem Diabetes Care Inc Fourth Quarter Earnings Conference Call for 20242025-02-26T16:30:00
Tandem Diabetes Care Inc Annual Report for 20242025-02-26T00:00:00
Tandem Diabetes Care Inc Fourth Quarter Earnings Result for 20242025-02-26T00:00:00
Citi’s 2024 Global Healthcare Conference2024-12-04T13:00:00
36th Annual Piper Sandler Healthcare Conference2024-12-03T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.